Mark Schreuder

Dr. Mark Schreuder is an Adjunct Associate Professor in the School of Medical Sciences at the University of Sydney's Faculty of Medicine and Health. His research focuses on thrombosis, hemostasis, and cancer metabolism, with a particular interest in the interplay between metabolic pathways and disease progression. He is a member of the Charles Perkins Centre, contributing to interdisciplinary research in these areas.

Research Interests:

• Coagulation mechanisms and factor interactions (e.g., Factor Xa, Factor Va)
• Cancer metabolism, including fatty acid and glutamine utilization in prostate and breast cancers
• Development of radiopharmaceuticals for cell death imaging
• Anticoagulant therapies and reversal agents

Publications reflect a focus on thrombosis biology, cancer metabolic pathways, and translational research in drug development. Recent work includes preclinical studies on novel hsp90 ligands for PET imaging and investigations into snake venom-derived proteins' roles in coagulation.

Scientific Awards: None explicitly listed.

Advising/Grants: No specific advising or grant details provided in the text.

Labs/Teams: Active member of the Charles Perkins Centre, collaborating on metabolic and translational research projects.